
Please try another search
Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestinal, infectious diseases, immunology, rheumatology, pediatrics, and nutritional supplements, etc. In addition, the company offers contract and toll manufacturing services. The company provides its products under the Pemro, Nivomab, Xelpac Premium, Docexan, Xaloplat Aqua, Gemoxen Aqua, ETP, FXR, Renesis, Mezest, Eposis, Tirza, Xelmet, Xerova, Sinjard, Ovocal, Haxinor, Tetrazin, Lubilux, Paloxi, Olonex, and Bukof brand name. Beacon Pharmaceuticals PLC was incorporated in 2001 and is based in Dhaka, Bangladesh.
Name | Age | Since | Title |
---|---|---|---|
Mohammad Ebadul Karim | 68 | - | MD & Director |
Nurun Nahar Karim | 65 | - | Chairman |
Ulfat Karim | - | 2023 | COO & Director |
Mohammad Niazul Karim | 40 | 2006 | Director |
ABM Faroque | - | 2024 | Independent Director |
Rezanur Chowdhury | - | - | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review